Prognostic factors in carcinomas of unknown primary site

被引:0
|
作者
Seve, P. [2 ,3 ]
Culine, S. [1 ]
机构
[1] CHU Henri Mondor, Med Oncol Serv, F-94010 Creteil, France
[2] Hosp Civils Lyon, Serv Med Interne, F-69288 Lyon 02, France
[3] Univ Lyon 1, Fac Med Lyon Sud, F-69622 Villeurbanne, France
关键词
Carcinoma of unknown primary (CUP); Prognostic factors;
D O I
10.1007/s10269-008-0970-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinomas of unknown primary (CUP) site are a heterogeneous group of tumours with widely variable natural histories and poor survival rates. In a minority of patients, the clinical presentation similar to that of known primar cancers at an equivalent stage has resulted in the identification of subsets of patients with favourable clinical and pathological features. Their recognition is of major importance since specific management may prolong survival. For the vast majority of patients with CUP however, the identification of reliable prognostic indicators has proven challenging. A number of studies with multivariate analyses identified poor performance status, liver metastases, abnormal serum lacticodehydrogenase levels, and low serum albumin as main recurrent adverse prognostic factors. Adequate knowledge of prognostic factors may help oncologists in refining the daily management of patients, assessing the results and designing clinical research studies.
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [41] The prognostic impact of the putative primary site of breast and ovarian cancers in an unfavorable subset of cancer of unknown primary site
    Kodaira, M.
    Yonemori, K.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site - Author reply
    Seve, Pascal
    Hanson, John
    CANCER, 2007, 109 (12) : 2624 - 2624
  • [43] PACLITAXEL, CISPLATIN AND GEMCITABINE IN THE TREATMENT OF CARCINOMAS OF UNKNOWN PRIMARY SITE, A PHASE II STUDY
    Moller, A. K. H.
    Damgaard, K.
    Nelausen, K.
    Daugaard, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 247 - 247
  • [44] Hepatic metastases from carcinomas of unknown primary site - Experience of the Montpellier Cancer Center
    Pouessel, D
    Thezenas, S
    Culine, S
    Becht, C
    Senesse, P
    Ychou, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (12): : 1224 - 1232
  • [45] Hybrid Model Integrating Immunohistochemistry and Expression Profiling for the Classification of Carcinomas of Unknown Primary Site
    Centeno, Barbara A.
    Bloom, Gregory
    Chen, Dung-Tsa
    Chen, Zhihua
    Gruidl, Mike
    Nasir, Aejaz
    Yeatman, Timothy Y.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (04): : 476 - 486
  • [46] Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study
    Moller, Anne Kirstine Hundahl
    Pedersen, Karen Damgaard
    Gothelf, Anita
    Daugaard, Gedske
    ACTA ONCOLOGICA, 2010, 49 (04) : 423 - 430
  • [47] Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site
    Lesimple, T
    Voigt, JJ
    Bataillard, A
    Coindre, JM
    Culine, S
    Lortholary, A
    Merrouche, Y
    Ganem, G
    Kaminsky, MC
    Negrier, S
    Perol, M
    Bedossa, P
    Bertrand, G
    Bugat, B
    Fizazi, K
    BULLETIN DU CANCER, 2003, 90 (12) : 1071 - 1096
  • [48] MOLECULAR AND CYTOGENETIC STUDIES IN THE DIAGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED CARCINOMAS OF UNKNOWN PRIMARY SITE
    MOTZER, RJ
    RODRIGUEZ, E
    REUTER, VE
    BOSL, GJ
    MAZUMDAR, M
    CHAGANTI, RSK
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 274 - 282
  • [49] Analysis of Biological Markers, Tumoral Predictors and Clinical Features as Prognosis Factors to Cnemotherapy Response in Metastatic Carcinomas of Unknown Primary Site
    Grajales-Alvarez, R.
    Martinez-Martinez, G.
    Martin-Aguilar, A. E.
    Silva, J. A.
    Astudillo-de la Vega, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S138 - S139
  • [50] Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study
    Kuo-Wei Chen
    Chia-Jen Liu
    Hsueh-Ju Lu
    Cheng-Hwai Tzeng
    Jin-Hwang Liu
    Tzeon-Jye Chiou
    Chueh-Chuan Yen
    Wei-Shu Wang
    Ta-Chung Chao
    Hao-Wei Teng
    Ming-Huang Chen
    Chun-Yu Liu
    Peter MH Chang
    Muh-Hwa Yang
    BMC Research Notes, 5 (1)